Platelet Rich Plasma Injections in Young and Old Human Subjects
Phase 2
60
about 1.5 years
18–70
1 site in CA
What this study is about
This trial is testing platelet-rich plasma (PRP) injections for knee osteoarthritis. This is a phase 2 randomized, double-blind, placebo-controlled trial with a secondary crossover phase at the end of the initial trial to ensure all subjects receive one PRP injection. The goal is to identify what proteins change in the blood following repeated intraarticular knee PRP injections in patients with knee osteoarthritis.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Control saline injection
- 2.Take Platelet-Rich Plasma (PRP) Injections
- 3.Use Centrifuge
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
injection
Musculoskeletal